ArticleVaccines2025

Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.

Andrea Duminuco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.